Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Sumitomo Chemical Co ( (JP:4005) ) has issued an update.
Sumitomo Chemical Co. reported variances in the non-consolidated financial results of its subsidiaries for fiscal years 2024 and 2023. Sumitomo Pharma Co., Ltd. saw significant improvements in net sales and income due to increased sales in North America and China, alongside reduced expenses. Taoka Chemical Co., Ltd. experienced growth in sales and income driven by higher sales of resin raw materials and cost-cutting measures. The overall impact on Sumitomo Chemical’s consolidated financial forecast is considered immaterial.
The most recent analyst rating on (JP:4005) stock is a Hold with a Yen370.00 price target. To see the full list of analyst forecasts on Sumitomo Chemical Co stock, see the JP:4005 Stock Forecast page.
More about Sumitomo Chemical Co
Sumitomo Chemical Co. operates in the chemical industry, focusing on pharmaceuticals and chemical products. Its primary subsidiaries include Sumitomo Pharma Co., Ltd., which is involved in the pharmaceutical sector, and Taoka Chemical Co., Ltd., which specializes in chemical products like resin raw materials.
Average Trading Volume: 11,265,629
Technical Sentiment Signal: Sell
Current Market Cap: Yen585.5B
For detailed information about 4005 stock, go to TipRanks’ Stock Analysis page.